Estimating the risks and benefits of nicotine replacement therapy for smoking cessation in the United States

American Journal of Public Health

Volumn 100, Issue 2, 2010, Pages 341-348

  Apelberg, Benjamin J ^a   Onicescu, Georgiana ^a   Avila Tang, Erika ^a   Samet, Jonathan M ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

ARTICLE; COMPUTER SIMULATION; COST BENEFIT ANALYSIS; HUMAN; MONTE CARLO METHOD; MORTALITY; RISK; SMOKELESS TOBACCO; SMOKING; SMOKING CESSATION; UNITED STATES;

COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; HUMANS; MONTE CARLO METHOD; NICOTINE; RISK; SMOKING; SMOKING CESSATION; TOBACCO, SMOKELESS; UNITED STATES;

EID: 75649100516     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2008.147223     Document Type: Article

References (50)

1. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000. JAMA. 2004; 291(10): 1238-1245.
2. Centers for Disease Control and Prevention. Annual smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 1997-2001. MMWR Morb Mortal Wily Rep. 2005; 54(25): 625-628.
3. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ. 2004; 328(7455): 1519-1527. (Pubitemid 38850305)
4. Summary Health Statistics for U.S. Adults: National Health Interview Survey, 2005. Provisional Report. Hyattsville, MD: US Department of Health and Human Services, Caiters for Disease Control and Prevention, National Center for Health Statistics; 2006. DHHS publication no. 2007-11560
5. Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 2000. MMWR Morb Mortal Wkly Rep. 2002; 51(29): 642-645.
6. The Health Benefits of Smoking Cessation. A Report of the Surgeon General Washington, DC: US Department of Health and Human Services; 1990.
7. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2004; (3): CD000146.
8. Benowitz NL. The role of nicotine in smoking-related cardiovascular disease. Prev Med. 1997; 26(4): 412-417. (Pubitemid 27314091)
9. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997; 29(7): 1422-1431. (Pubitemid 27272432)
10. Khosla. S, Laddu A, Ehrenpreis S, Somberg JC. Cardiovascular effects of nicotine: relation to deleterious effects of cigarette smoking. Am Heart. J. 1994; 127(6): 1669-1.672.
11. Balfour D, Benowitz N, Fagerstrom K, Kunze M, Keil U Diagnosis and treatment of nicotine dependence with emphasis on nicotine replacement therapy. A status report. Eur Heart J. 2000; 21(6): 438-445. (Pubitemid 30122131)
12. Haustein KO. Smoking tobacco, microcirculatory changes and the role of nicotine. Int J Clin Pharmacol Ther. 1999; 37(2): 76-85. (Pubitemid 29074184)
13. Joseph AM, Norman. SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med. 1996; 335(24): 1792-1798.
14. Tzivoni D, Keren A, Meyler S, Khoury Z, Lerer T, Brunel P. Cardiovascular safety of transdermal nicotine patches in patients with coronary artery disease who try to quit smoking. Cardiovasc Drugs Ther. 1998; 12(3): 239-244.
15. Cooke JP, Bitterman H. Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann Med. 2004; 36(1):33-40. (Pubitemid 38230697)
16. Catassi A, Servent D, Paleari L, Cesario A, Russo P. Multiple roles of nicotine on cell proliferation and inhibition of apoptosis: implications on lung carcinogenesis. Mutal Res. 2008; 659(3): 221-231.
17. Zeidler R, Albermann K, Lang S. Nicotine and apoptosis. Apoptosis. 2007; 12(11): 1927-1943.
18. -2005 National Health Interview Survey (NHIS) public use data release: NHLS survey description. Hyattsville, MD: National Center for Health Statistics, Division of Health Interview Statistics; 2006.
19. Hughes JR, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction. 2004: 99(1): 29-38. (Pubitemid 38142221)
20. Stellman SD, Garfinkel L. Smoking habits and tar levels in a new American Cancer Society prospective study of 1.2 million men and women. J Natl Cancer Inst. 1986: 76(6): 1057-1063. (Pubitemid 16093139)
21. Changes in Cigarette-Related Disease Risks and Their Implication for Prevention and Control Bums DM, Gar finkel L, Samet JM, eds. Bethesda, MD: US Department of Health and Human Services, Public Health Service, National Cancer Institute; 1997. NIH publication no. 974213. Smoking and Tobacco Control Monograph.
22. Centers for Disease Control and Prevention. Cigarette smoking among adults-United States, 2006. MMWR Morb Mortal Wkly Rep. 2007; 56(44): 1157-1161.
23. Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health. 1994; 84(3): 399-404. (Pubitemid 24107823)
24. Cummings KM, Hyland A, Giovino GA, Hastrup JL, Bauer JE, Bansal MA. Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine Tob Res. 2004; 6 Suppl 3: S333-S340.
25. Bansal MA, Cummings KM, Hyland A, Giovino GA. Stop-smoking medications: who uses them, who misases them, and who is misinformed about them? Nicotine Tob Res. 2004; 6 Suppl 3: S303-S310.
26. Kilaru S, Frangos SG, Chen AH, et al. Nicotine: a review of its role in atherosclerosis. JAm Coll Surg. 2001; 193(5): 538-546. (Pubitemid 33043458)
27. Joseph AM, Fu SS. Safety issues in pharmacotherapy for smoking in patients with cardiovascular disease. Prog Cardiovasc Dis. 2003; 45(6): 429-441. (Pubitemid 36666451)
28. Benowitz NL. Smoking-induced coronary vasoconstriction: implications for therapeutic use of nicotine. J Am Coll Cardiol. 1993; 22(3): 648-649.
29. Van Gilder TJ, Remington PL, Fiore MC. The direct effects of nicotine use on human health. Wis Med J. 1997; 96(2): 43-48.
30. US Department of Health and Human Services, National Cancer Institute. Risks Associated With Smoking Cigarettes With Low Machine-Measured Yields of Tar and Nicotine. Bethesda, MD: National Institutes of Health; 2001.
31. Greenland S, Satterfield MH, Lanes SF. A metaanalysis to assess the incidence of adverse effects associated with the transdermal nicotine patch. Drug Saf. 1998; 18(4): 297-308. (Pubitemid 28177293)
32. Meine TJ, Patel MR, Washam JB, Fappas PA, Jollis JG. Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. AmJ Cardiol 2005; 95(8): 976-978.
33. Hubbard R, Lewis S, Smith C, et al. Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death. Tob Control. 2005; 14(6): 416-421. (Pubitemid 41759617)
34. Kimmel SE, Berlin JA, Miles C, Jaskowiak J, Carson JL, Strom BL. Risk of acute first myocardial infarction and use of nicotine patches in a general population. J Am Coll Cardiol. 2001; 37(5): 1297-1302.
35. Evan GI, Vousden KH Proliferation, cell cycle and apoptosis in cancer. Nature. 2001; 411(6835): 342-348.
36. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature. 2000; 407(6801): 249-257.
37. Benowitz NL, Jacob P III, Yu L. Daily use of smokeless tobacco: systemic effects. Ann Intern Med. 1989; 111(2): 112-116. (Pubitemid 19180321)
38. Smokeless Tobacco or Health: An International Perspective. Rockville, MD: National Cancer Institute; 1992.
39. Gupta R, Gurm H, Bartholomew JR. Smokeless tobacco and cardiovascular risk. Arch Intern Med 2004; 164(17): 1845-1849.
40. Asplund K Smokeless tobacco and cardiovascular disease. Prog Cardiovasc Dis. 2003; 45(5): 383-394.
41. Daniel Roth H, Roth AB, Liu X. Health risks of smoking compared to Swedish snus. Inhal Toxicol. 2005; 17(13): 741-748. (Pubitemid 41504533)
42. Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long-term use of Swedish moist snuff and the risk of myocardial infarction amongst men. J Intern Med 2007; 262(3): 351-359. (Pubitemid 47246970)
43. Luo J, Ye W, Zendehdel K, et al. Oral use of Swedish moist snuff (snus) and risk for cancer of the mouth, lung, and pancreas in male construction workers: a retrospective cohort study. Lancet 2007; 369(9578): 2015-2020. (Pubitemid 46899161)
44. Zendehdel K, Nyren O, Luo J, et al. Risk of gastroesophageal cancer among smokers and users of Scandinavian moist snuff. Int J Cancer. 2008; 122(5): 10951099. (Pubitemid 351214008)
45. Manser RL, Irving LB, Stone C, Byrnes G, Abramson M, Campbell D. Screening for lung cancer. Cochrane Database Syst Rev. 2004; (1): CD001991.
46. Cancer traids progress report-2005 update. Bethesda, MD: National Cancer Institute; 2005.
47. AHCPR Supported Clinical Practice Guidelines. 18. Treating tobacco use and dependence: 2008 update. Rockville, MD: Agency for Healthcare Research and Quality, US Department of Health and Human Services; 2008.
48. Centers for Disease Control and Prevention. Incidence of initiation of cigarette smoking-United States, 1965-1996. MMWR Morb Mortal Wkly Rep. 1998; 47(39): 837-840.
49. National Cancer Institute. Those Who Continue to Smoke: Is Achieving Abstinence Harder and Do We Need to Change Our Interventions? Rockville, MD: US Department of Health and Human Services; 2003. Smoking and Tobacco Control Monograph 15.
50. The Health Effects of Active Smoking: A Report of the Surgeon General. Washington, DC: US Department of Health and Human Services; 2004.